{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:17:17Z","timestamp":1786979837702,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T00:00:00Z","timestamp":1178150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T00:00:00Z","timestamp":1178150400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urol Res"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1007\/s00240-007-0096-2","type":"journal-article","created":{"date-parts":[[2007,5,3]],"date-time":"2007-05-03T13:20:32Z","timestamp":1178198432000},"page":"123-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Biochemical characterization of primary hyperparathyroidism with and without kidney stones"],"prefix":"10.1007","volume":"35","author":[{"given":"Clarita V.","family":"Odvina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khashayar","family":"Sakhaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard J.","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy D.","family":"Peterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Poindexter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulette K.","family":"Padalino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Y. C.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,5,3]]},"reference":[{"key":"96_CR1","first-page":"46","volume-title":"Clinical hyperparathyroidism. The parathyroid glands and metabolic bone disease","author":"F Albright","year":"1948","unstructured":"Albright F, Reifenstein EC 1948 Clinical hyperparathyroidism. The parathyroid glands and metabolic bone disease. Williams & Wilkins, Baltimore, pp 46\u2013121"},{"key":"96_CR2","first-page":"236","volume":"ii","author":"CE Dent","year":"1961","unstructured":"Dent CE, Hartland BV, Hicks J, Sykes ED (1961) Calcium intake in patients with primary hyperparathyroidism. Lancet ii:236\u2013242","journal-title":"Lancet"},{"key":"96_CR3","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1210\/jc.2006-0857","volume":"92","author":"A Scillitani","year":"2007","unstructured":"Scillitani A, Guarnieri V, Battista C, De Geronimo S, Muscarella LA, Chiodini I et al (2007) Primary hyperparathyroidism and the presence of kidney stones are associated with different haloptypes of calcium-sensing receptor. J Clin Endocrinol Metab 92:277\u2013283","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR4","first-page":"78","volume-title":"Calcium regulating hormones","author":"M Peacock","year":"1975","unstructured":"Peacock M (1975) Renal stones disease and bone disease in primary hyperparathyroidism and their relationship to the action of parathyroid hormone on calcium absorption. In: Talmadge R (ed) Calcium regulating hormones. Excepta Medica, Amsterdam, pp 78\u201381"},{"key":"96_CR5","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1056\/NEJM198002213020801","volume":"302","author":"AE Broadus","year":"1980","unstructured":"Broadus AE, Horst RL, Lang R, Littledike ET, Rasmussen H (1980) The importance of circulating concentration of 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. N Engl J Med 302:421\u2013426","journal-title":"N Engl J Med"},{"key":"96_CR6","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jcem-53-3-536","volume":"53","author":"CYC Pak","year":"1981","unstructured":"Pak CYC, Nicar MJ, Peterson R, Zerwekh JE, Snyder W (1981) A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism. J Clin Endocinol Metab 53:536\u2013542","journal-title":"J Clin Endocinol Metab"},{"key":"96_CR7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/ki.1987.125","volume":"31","author":"P Patron","year":"1987","unstructured":"Patron P, Jean-Paul G, Paillard M (1987) Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney Int 31:1174\u20131170","journal-title":"Kidney Int"},{"key":"96_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0002-9343(90)90346-F","volume":"89","author":"SJ Silverberg","year":"1990","unstructured":"Silverberg SJ, Shane E, Jacobs TP, Siris ES, Gartenberg F, Seldin D et al (1990) Ephrolithiasis and bone involvement in primary hyperparathyroidism. Am J Med 89:327\u2013334","journal-title":"Am J Med"},{"key":"96_CR9","first-page":"359","volume":"18","author":"A D\u2019Angelo","year":"1992","unstructured":"D\u2019Angelo A, Lodetti MG, Giannini S, Castrignano R, al Awady M, Malvasi L et al (1992) Hyperparathyroidism: cause or consequence of recurrent calcium nephrolithiasis? Min Electrolyte Metab 18:359\u2013364","journal-title":"Min Electrolyte Metab"},{"key":"96_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF03345354","volume":"28","author":"S Corbetta","year":"2005","unstructured":"Corbetta S, Baccarelli A, Aroldi A, Vicentini L, Fogazzi GB, Eller-Vainicher C et al. (2005) Risk factors associated with kidney stones is primary hyperparathyroidism. J Endocrinol Invest 28:122\u2013128","journal-title":"J Endocrinol Invest"},{"key":"96_CR11","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0039-6060(96)80051-1","volume":"120","author":"JA Soreide","year":"1996","unstructured":"Soreide JA, von Heerden JA, Grant CS, Lo CY, Ilstrup DM (1996) Characteristics of patients surgically treated for primary hyperparathyroidism with and without renal stones. Surgery 120:1033\u20131038","journal-title":"Surgery"},{"key":"96_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/PL00013175","volume":"23","author":"CL Mollerup","year":"1999","unstructured":"Mollerup CL, Lindewald DH (1999) Renal stones and primary hyperparathyroidism: natural history and renal stone disease after parathyroidectomy. W J Surg 23:173\u2013176","journal-title":"W J Surg"},{"key":"96_CR13","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s00268-001-0262-6","volume":"26","author":"VG Frokjaer","year":"2002","unstructured":"Frokjaer VG, Mollerup CL (2002) Primary hyperparathyroidism: renal calcium excretion in patients with and without renal stone disease before and after parathyroidectomy. W J Surg 26:532\u2013535","journal-title":"W J Surg"},{"key":"96_CR14","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1210\/jcem-47-4-751","volume":"47","author":"AE Broadus","year":"1978","unstructured":"Broadus AE, Dominguez M, Bartter FC (1978) Pathophysiological studies in idiopathic hypercalciuria: use of an oral calcium tolerance test to characterize hypercalciuric subgroups. J Clin Endocrinol Metab 47:751\u2013760","journal-title":"J Clin Endocrinol Metab"},{"key":"96_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJM197503062921002","volume":"292","author":"CYC Pak","year":"1975","unstructured":"Pak CYC, Kaplan RA, Bone H, Townsend J, Waters O (1975) A simple test for the diagnosis of absorptive, resorptive and renal hypercalciurias. N Eng J Med 292:497\u2013500","journal-title":"N Eng J Med"},{"key":"96_CR16","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1097\/01.ju.0000136400.14728.cd","volume":"172","author":"K Sakhaee","year":"2004","unstructured":"Sakhaee K, Poindexter J, Griffith CS, Pak CYC (2004) Stone-forming risk of calcium citrate supplementation in healthy postmenopausal women. J Urol 172:958\u2013961","journal-title":"J Urol"},{"key":"96_CR17","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/ki.1997.126","volume":"51","author":"JH Parks","year":"1997","unstructured":"Parks JH, Coward M, Coe FL (1997) Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int 51:894\u2013900","journal-title":"Kidney Int"},{"key":"96_CR18","first-page":"153","volume-title":"Urolithiasis: a medical, surgical reference","author":"CYC Pak","year":"1990","unstructured":"Pak CYC (1990) General guidelines in medical evaluation. In: Resnick MI, Pak CYC (eds) Urolithiasis: a medical, surgical reference. WB Saunders, Philadelphia, pp 153\u2013172"},{"key":"96_CR19","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/S0022-5347(17)47703-2","volume":"134","author":"PG Werness","year":"1985","unstructured":"Werness PG, Brown CM, Smith L, Finlayson B (1985) EQUIL 2: a basic computer program for the calculation of urinary saturation. J Urol 134:1242\u20131244","journal-title":"J Urol"},{"key":"96_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(75)92950-5","volume":"ii","author":"CYC Pak","year":"1975","unstructured":"Pak CYC, Stewart A, Kaplan R, Bone H, Notz C, Browne R (1975) Photon absorptiometric analysis of bone density in primary hyperparathyroidism. Lancet ii:7\u201310","journal-title":"Lancet"},{"key":"96_CR21","first-page":"727A","volume":"26","author":"LH Smith","year":"1978","unstructured":"Smith LH, Werness PG, Lee KE, Berget JH, Wison DM (1978) Inhibitors of crystal growth and aggregation in calcium urolithiasis. Clin Res 26:727A","journal-title":"Clin Res"},{"key":"96_CR22","first-page":"146","volume":"17","author":"CYC Pak","year":"1979","unstructured":"Pak CYC (1979) Effect of parathyroidectomy on crystallization of calcium salts in urine of patients with primary hyperparathyroidism. Invest Urol 17:146\u2013148","journal-title":"Invest Urol"}],"container-title":["Urological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-007-0096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00240-007-0096-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-007-0096-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00240-007-0096-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T18:10:15Z","timestamp":1652897415000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00240-007-0096-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["96"],"URL":"https:\/\/doi.org\/10.1007\/s00240-007-0096-2","relation":{},"ISSN":["0300-5623","1434-0879"],"issn-type":[{"value":"0300-5623","type":"print"},{"value":"1434-0879","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,5,3]]},"assertion":[{"value":"23 August 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2007","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2007","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}